Relevant to the latter findings, a reduction in airway levels of IL-8 and LTB4 in individuals with cystic fibrosis (CF) treated with aerosolized AAT has been reported,93 suggesting the use of AAT outside of the context of AATD. This evidence concerns the gene CXCL8 and cystic fibrosis.